Joint Chiefs Urge “Due Diligence” in Targeting the Enemy
The proper selection and validation of enemy targets in war is a critical function for military planners and intelligence analysts. Errors can result in horrific civilian casualties and may also be strategically counterproductive.
“In extreme cases, failure to exercise due diligence in target development can result in outcomes that have negative strategic repercussions for the United States and its allies,” a newly disclosed Pentagon manual on targeting acknowledges (in bold type).
Procedures for correctly identifying and approving targets are described in the manual. See Target Development Standards, Chairman of the Joint Chiefs of Staff Instruction 3370.01B, 230 pages, 6 May 2016 (Unclassified, For Official Use Only).
A target is “an entity or object that performs a function for the adversary considered for possible engagement or other action,” the manual explains.
“Targets fall into one of five target types: facility, individual, virtual, equipment, or organization.”
“Examples include POL [petroleum, oil or lubricant] or PWR [electric power] sites (facilities), the chief accountant of a terrorist group (individual), a Web site (virtual), mobile radar (equipment), or a motorized infantry brigade (organization).”
“A terrorist network is the adversary, not a target. A front company (an entity) that ships lethal aid (a function) for the terrorist network (the adversary) would be a target.”
“Collateral effects are unintentional or incidental adverse consequences of target engagement. Such effects are not unlawful so long as it is not excessive in light of the overall military advantage anticipated from the engagement.”
“While all targets are entities, not all entities in the battlespace are valid targets. To be validated as a target, the function of the entity must be tied to commander’s objectives (operationally relevant) and meet Law of War (LOW) requirements,” the manual notes.
The manual applies to the Department of Defense and the military services. It does not govern lethal operations by the Central Intelligence Agency.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.
OPM’s new HR 2.0 initiative is entering hostile terrain. Those who have followed federal HR modernization for years desperately want this effort to succeed.